Protalix Biotherapeutics, Inc. (PLX)
2.03
+0.02
(+1.00%)
USD |
NYAM |
May 21, 16:00
2.035
0.00 (0.00%)
After-Hours: 19:59
Protalix Biotherapeutics Research and Development Expense (TTM) : 21.52M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Agenus, Inc. | 69.64M |
| Lisata Therapeutics, Inc. | 6.55M |
| Curis, Inc. | 26.16M |
| LadRx Corp. | 0.7712M |
| Plus Therapeutics, Inc. | 9.488M |